Milestone makes second-round investment in Salpep

Guest Contributor
June 21, 2002

Salpep Biotechnology Inc has received a second round of financing from Milestone Medica Corp, raising its financing to date to $1 million. The Calgary-based firm’s successful completion of preclinical milestones triggered the funding, by showing the efficacy of its anti-inflammatory compounds in pre-clinical models of asthma. The new funding will allow Salpep to continue with its pre-clinical development program and seek a partner for its asthma compounds. University Medical Discoveries Inc is also an investor in the univer


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.